It also reduces FGF-2 [46], VEGF, and IL-6 secretion by BMSCs and MM cells [47], stimulating the activation and expansion of T cells and enhancing NK-cell-mediated cytotoxicity. The gene discussed is FGF2; the disease is Miyoshi myopathy.